Shelter Pharma: No Deviation in Preferential Issue Fund Utilization

Shelter Pharma Ltd confirmed no deviation or variation in the utilization of proceeds from its Preferential Issues of Warrants convertible into Equity Shares for the half year and year ended March 31, 2026. The company raised ₹25.31 Cr (Rs. 2531.2 lakhs) through this preferential issue, which was approved in an Extraordinary General Meeting held on July 23, 2025. The entire amount was allocated and fully utilized for working capital requirements as per the approved objects. The statement of deviation, confirming no deviation, was duly reviewed by the Audit Committee and certified by the company's auditors.